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The United States has well-documented rural–urban health disparities, and it is imperative that these are not exacerbated by an in-
efficient rollout of coronavirus disease 2019 (COVID-19) vaccines to rural areas. In addition to the preexisting barriers to delivering 
and receiving health care in rural areas, such as high patient:provider ratios and long geographic distances between patients and 
providers, rural residents are significantly more likely to say they have no intention of receiving a COVID-19 vaccine, compared with 
urban residents. To overcome these barriers and ensure that rural residents receive the vaccine, officials and communities should 
look to previous research on how to communicate vaccine information and implement successful vaccination programs in rural 
areas for guidance and concrete strategies to use in their local efforts.
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In early 2020, the majority of corona-
virus disease 2019 (COVID-19) cases 
were in urban parts of the United States, 
and the conversation was focused on 
how to disseminate and implement pre-
vention strategies in rural areas [1]. 
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Unfortunately, there are now cases of 
COVID-19 in nearly every rural com-
munity in the United States, and some 
have seen cases increase at a faster rate 
than anywhere else in the country [2]. If 
there was a hope that rural America could 
be spared the brunt of the pandemic, that 
hope is long gone.
Fortunately, with the approval of ef-
fective vaccines, the conversation is 
now shifting to disseminating vaccine 
information and implementing vaccin-
ations [3], particularly in rural areas. 
A  recent study found that rural resi-
dents were significantly more likely to 
say they had no intention of receiving 
the vaccine, compared with urban resi-
dents [4]. Ensuring that rural residents 
receive the vaccine means taking into 
consideration the challenges and cul-
tural context in rural areas. Looking to 
previous research on how to commu-
nicate vaccine information and imple-
ment successful vaccination programs 
in rural areas can offer guidance and 
concrete strategies that officials and 
communities can use in their local 
efforts.
IMPORTANCE OF COMMUNITY 
LEADERS AND ORGANIZATIONS
Community leaders and organizations 
influence the community on many 
topics, including health. In a study of the 
human papillomavirus (HPV) vaccine in 
rural areas, religiosity was an important 
factor in whether parents chose to vacci-
nate their children [5]. Parents reported 
that their vaccine-related decisions and 
beliefs were influenced by other church 
members and saw the church as an ac-
tive disseminator of health information. 
In fact, most parents reported a desire for 
their pastors to present information spe-
cifically on the HPV vaccine. Parents who 
did not report this desire indicated that 
this was driven by concern that the pastor 
lacked the training to discuss the topic 
and that it was better left to someone ed-
ucated on the vaccine. If religious leaders 
were informed and educated about the 
COVID-19 vaccines, there might be wide 
acceptability in them discussing the topic 
with their congregations.
In another study, researchers imple-
mented a comprehensive, community-
wide campaign to increase HPV vaccine 
rates among children [6]. Their campaign 
included presentations about the vaccine 
and HPV at school- and community-
based events. They also distributed ed-
ucational materials to health clinics in 
the community and, importantly, used 
Facebook, local radio stations, and news-
papers to provide a description of their 
program and advertise events. Using 
this approach, they were able to signifi-
cantly increase vaccination rates among 
children in the community.
ROLE OF SOCIAL MEDIA AND 
INTERNET
Social media and the Internet should 
be leveraged in the dissemination of in-
formation about the COVID-19 vaccines. 
In a study of women in rural Kentucky, 
anonymous sources of health information 
were preferred to interpersonal sources, 
such as a family member, friend, or health 
care professional [7]. Concern about 
stigma was associated with preferring an 
anonymous source, and the internet was 
the most preferred anonymous source. 
Given that rural Americans report having 
less intention to get a COVID-19 vaccine 
[4] and given the influence of community 
leaders and friends/family on health in-
tentions, having accurate but anonymous 
sources of information about COVID-19 
vaccines, especially on the internet and 
social media, will be critically important 
to ensuring that all those who want to 
learn about the vaccines can do so.
In a separate study, researchers looking 
at the uptake of the influenza vaccine in 
one rural town found that both residents 
who received the vaccine and those who 
did not believed the vaccine was afford-
able, convenient, and quick to receive 
[8]. The main difference between those 
who received the vaccine and those who 
did not was whether they believed the 
vaccine made them sick and whether 
they believed getting the vaccine was 
worthwhile (the former being associated 
with not receiving the vaccine and the 
latter with receiving it). However, half 
of those who believed the vaccine was 
worthwhile still did not get it. This sug-
gests that there are additional barriers to 
receiving the vaccine that are not related 
to affordability, access, or worth, and per-
haps facilitating the dissemination of ac-
curate information via trusted channels, 
such as community leaders and social 
networks, could overcome these barriers.
ALTERNATIVE DISTRIBUTION 
SITES AND MODELS
Given the challenges of providing and 
receiving health care in rural areas [9, 
10], vaccine rollout will certainly require 
specialized strategies. In a study of the 
differences in location of influenza vac-
cinations, those in rural areas were more 
dependent on traditional, clinical loca-
tions, such as a physician’s office, hos-
pital, or health department, than those 
in urban areas [11]. The authors believed 
this was due to a lack of alternative dis-
tribution sites such as retail clinics or 
pharmacies in rural areas. The lack of al-
ternative distribution sites in rural areas, 
as well as the overall lack of clinical sites, 
likely contributes to the overall lower 
vaccination rates in rural areas [12, 13]. 
Therefore, increasing both clinical and 
alternative distribution sites may signifi-
cantly increase access to COVID-19 vac-
cines in rural areas.
Pharmacies are one such alternative 
distribution site for which there is con-
siderable evidence of effectiveness. In 1 
study of vaccine distribution in Texas, 
if pharmacists were considered vac-
cine providers, 18% of previously in-
adequately covered rural census tracts 
(defined by provider-to-resident ratio) 
would become adequately covered [14]. 
In addition to pharmacists being more 
geographically dispersed in rural areas, 
rural residents frequently report positive 
relationships with their pharmacists [15], 
which could facilitate residents seeking 
out a COVID-19 vaccine (or informa-
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pharmacies are already aware of the im-
portant role they could play in vaccine 
distribution [16].
Despite the promise of rural phar-
macies as vaccine distribution sites, the 
number of independent pharmacies in 
rural areas has been steadily declining 
[17], and therefore additional alterna-
tive vaccine distribution sites must be 
explored. Often taking the form of vans, 
mobile health units or clinics (MHUCs) 
can successfully reach rural residents 
who do not have adequate access to other 
types of health care [18]. MHUCs in rural 
Appalachia were found to mitigate many 
of the access barriers presented to rural 
residents [19]. The researchers also found 
that the private, trusted environment 
MHUCs offered, coupled with the fact 
that MHUCs often serve patients who do 
not receive routine health care, led to the 
discovery or disclosure of multiple prob-
lems with patients beyond their initial 
complaint [19]. For example, an MHUC 
may be specifically targeting breast cancer 
screening but during that encounter ad-
ditional concerns such as hypertension or 
intimate partner violence may be discov-
ered. This would also very likely be the 
case in the event that MHUCs are used 
to distribute COVID-19 vaccines, and 
as such, MHUCs should have protocols 
in place to address these additional con-
cerns. This may mean having additional 
providers on hand who are trained to 
triage these concerns or having a robust 
referral database to direct patients to for 
additional follow-up.
CONCLUSIONS
Nearly a year into this pandemic, there is 
finally a light at the end of the tunnel. We 
must now focus our efforts on ensuring 
that every rural resident who wants a 
COVID-19 vaccine receives one and, 
importantly, that rural residents are not 
the last to receive them. Despite the chal-
lenges to providing health care in rural 
areas, there are also, fortunately, effective 
strategies to overcome these challenges, 
specifically as they relate to vaccinations. 
Learning from and utilizing these existing 
evidence-based strategies can ensure that 
the COVID-19 vaccines are rolled out ef-
ficiently and equitably in rural areas.
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